Growth Metrics

C4 Therapeutics (CCCC) FCF Margin (2019 - 2026)

C4 Therapeutics' quarterly FCF Margin came in at 487.35% in Q1 2026, down 2749.0% year-on-year from 18.4% in Q1 2025, and down 142.31% quarter-over-quarter from 201.13% in Q4 2025.

C4 Therapeutics has reported FCF Margin for 8 years, with the latest figure at 487.35% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 2749.0% year-over-year to 487.35%; the trailing twelve-month figure through Mar 2026 stood at 275.37% (down 7302.0% YoY), and the FY2025 full-year result was 276.24%, down 9263.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 487.35%, down from 201.13% in the prior quarter.
  • The five-year high for FCF Margin was 41.54% in Q2 2024, with the low at 986.19% in Q4 2022.
  • Average FCF Margin over 5 years is 426.36%, with a median of 349.73% recorded in 2022.
  • Year-over-year, FCF Margin tumbled 85780 bps in 2022 and surged 67258 bps in 2024.
  • Tracing CCCC's FCF Margin over 5 years: stood at 986.19% in 2022, then surged by 30 bps to 689.24% in 2023, then soared by 50 bps to 346.3% in 2024, then surged by 42 bps to 201.13% in 2025, then sank by 142 bps to 487.35% in 2026.
  • The last three FCF Margin figures came in at 487.35% (Q1 2026), 201.13% (Q4 2025), and 280.58% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 C4 Therapeutics 561.03 Mn 325.36 Mn - -487.35%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -487.35%
Dec 31, 2025 -201.13%
Sep 30, 2025 -280.58%
Jun 30, 2025 -191.10%
Mar 31, 2025 -459.86%
Dec 31, 2024 -346.30%
Sep 30, 2024 -158.21%
Jun 30, 2024 -41.54%
Mar 31, 2024 -596.18%
Dec 31, 2023 -689.24%
Sep 30, 2023 -289.33%
Jun 30, 2023 -714.11%
Mar 31, 2023 -886.43%
Dec 31, 2022 -986.19%
Sep 30, 2022 -387.99%
Jun 30, 2022 -182.83%
Mar 31, 2022 -349.73%
Dec 31, 2021 -128.40%
Sep 30, 2021 -215.98%
Jun 30, 2021 -191.69%
Mar 31, 2021 -341.44%
Dec 31, 2020 -269.10%
Sep 30, 2020 -169.66%
Jun 30, 2020 -151.57%
Mar 31, 2020 -244.69%
Dec 31, 2019 -140.76%